• 5303 Citations
  • 36 h-Index
1977 …2022
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1978 2019

Article
18 Citations (Scopus)

Inhibition of hydroxymethylglutaryl coenzyme A reductase activity induces a paradoxical increase in DNA synthesis in myeloid leukemia cells

Hohl, R., Larson, R. A., Mannickarottu, V. & Yachnin, S., Jan 1 1991, In : Blood. 77, 5, p. 1064-1070 7 p.

Research output: Contribution to journalArticle

Myeloid Leukemia
Myeloid Cells
Coenzyme A
Oxidoreductases
DNA
54 Citations (Scopus)

Interaction of cytosine arabinoside and lovastatin in human leukemia cells

Holstein, S. A. & Hohl, R., Jun 11 2001, In : Leukemia Research. 25, 8, p. 651-660 10 p.

Research output: Contribution to journalArticle

Lovastatin
Cytarabine
Leukemia
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Cell Line
1 Citation (Scopus)

In vitro studies in a myelogenous leukemia cell line suggest an organized binding of geranylgeranyl diphosphate synthase inhibitors

Reilly, J. E., Zhou, X., Tong, H., Kuder, C. H., Wiemer, D. F. & Hohl, R., Jun 11 2015, In : Biochemical Pharmacology. 96, 2, p. 83-92 10 p.

Research output: Contribution to journalArticle

Farnesyltranstransferase
Myeloid Leukemia
Terpenes
Cells
Diphosphonates
10 Citations (Scopus)

Isoprenoid Alcohols Restore Protein Isoprenylation in a Time-Dependent Manner Independent of Protein Synthesis

Ownby, S. E. & Hohl, R., Jul 1 2003, In : Lipids. 38, 7, p. 751-759 9 p.

Research output: Contribution to journalArticle

Protein Prenylation
Prenylation
Lovastatin
Terpenes
Alcohols
26 Citations (Scopus)
Unfolded Protein Response
Biosynthetic Pathways
Terpenes
Multiple Myeloma
Proteins
17 Citations (Scopus)

Isoprenoid pyrophosphate analogues regulate expression of ras-related proteins

Holstein, S. A., Wohlford-Lenane, C. L., Wiemer, D. F. & Hohl, R., Apr 22 2003, In : Biochemistry. 42, 15, p. 4384-4391 8 p.

Research output: Contribution to journalArticle

ras Proteins
Terpenes
Diphosphates
Mevalonic Acid
Proteins
61 Citations (Scopus)

Isoprenoids influence expression of Ras and Ras-related proteins

Holstein, S. A., Wohlford-Lenane, C. L. & Hohl, R., Nov 19 2002, In : Biochemistry. 41, 46, p. 13698-13704 7 p.

Research output: Contribution to journalArticle

ras Proteins
Mevalonic Acid
Terpenes
Lovastatin
Up-Regulation
4 Citations (Scopus)

Lack of effect of casopitant on the pharmacokinetics of docetaxel in patients with cancer

Dandamudi, U. B., Adams, L. M., Johnson, B., Bauman, J., Morris, S., Murray, S., Webb, R. T., Gartner, E., Hohl, R. & Lewis, L. D., Apr 1 2011, In : Cancer Chemotherapy and Pharmacology. 67, 4, p. 783-790 8 p.

Research output: Contribution to journalArticle

docetaxel
Pharmacokinetics
Neoplasms
Cytochrome P-450 CYP3A
Cytochrome P-450 Enzyme System
32 Citations (Scopus)

Lovastatin alters the isoprenoid biosynthetic pathway in acute myelogenous leukemia cells in vivo

Lewis, K. A., Holstein, S. A. & Hohl, R., Jan 1 2005, In : Leukemia Research. 29, 5, p. 527-533 7 p.

Research output: Contribution to journalArticle

Lovastatin
Biosynthetic Pathways
Terpenes
Acute Myeloid Leukemia
Leukemia
32 Citations (Scopus)

Lovastatin inhibits T-cell antigen receptor signaling independent of its effects on ras

Goldman, F., Hohl, R. J., Crabtree, J., Lewis-Tibesar, K. & Koretzky, G., Dec 15 1996, In : Blood. 88, 12, p. 4611-4619 9 p.

Research output: Contribution to journalArticle

Lovastatin
T-Cell Antigen Receptor
Signal transduction
Phosphorylation
Inositol Phosphates
9 Citations (Scopus)

Lovastatin specifically prevents focal ischemic ventricular tachycardia due to triggered activity

Xing, D., Murry, D. J., Schmidt, M. S., Hohl, R. & Martins, J. B., May 1 2007, In : Heart Rhythm. 4, 5, p. 629-637 9 p.

Research output: Contribution to journalArticle

Lovastatin
Ventricular Tachycardia
Action Potentials
Mevalonic Acid
Dogs
15 Citations (Scopus)

Lovastatin suppresses erythropoietin receptor surface expression through dual inhibition of glycosylation and geranylgeranylation

Hamadmad, S. N. & Hohl, R. J., Aug 15 2007, In : Biochemical Pharmacology. 74, 4, p. 590-600 11 p.

Research output: Contribution to journalArticle

Erythropoietin Receptors
Prenylation
Glycosylation
Lovastatin
Erythropoietin
22 Citations (Scopus)

Low pulse oximeter-measured hemoglobin oxygen saturations with hemoglobin Cheverly

Hohl, R., Sherburne, A. R., Feeley, J. E., Huisman, T. H. J. & Burns, C. P., Nov 1 1998, In : American Journal of Hematology. 59, 3, p. 181-184 4 p.

Research output: Contribution to journalArticle

Pulse
Hemoglobins
Oxygen
phenylalanylserine
Mutation
33 Citations (Scopus)

Mono- and dialkyl isoprenoid bisphosphonates as geranylgeranyl diphosphate synthase inhibitors

Wiemer, A. J., Yu, J. S., Lamb, K. M., Hohl, R. & Wiemer, D. F., Jan 1 2008, In : Bioorganic and Medicinal Chemistry. 16, 1, p. 390-399 10 p.

Research output: Contribution to journalArticle

Protein Prenylation
Farnesyltranstransferase
Terpenes
Diphosphonates
Proteins
36 Citations (Scopus)

Monoterpene regulation of Ras and Ras-related protein expression

Holstein, S. A. & Hohl, R. J., Jun 1 2003, In : Journal of Lipid Research. 44, 6, p. 1209-1215 7 p.

Research output: Contribution to journalArticle

ras Proteins
Monoterpenes
Signal transduction
Proteins
Signal Transduction
34 Citations (Scopus)

Monoterpenes as regulators of malignant cell proliferation

Hohl, R., 1996, In : Advances in Experimental Medicine and Biology. 401, p. 137-146 10 p.

Research output: Contribution to journalArticle

Monoterpenes
perilla alcohol
Cell proliferation
Cell Proliferation
Prenylation
Open Access
decitabine
Acute Myeloid Leukemia
Therapeutics
T-Lymphocytes
DNA Methylation
30 Citations (Scopus)

Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas

Witzig, T. E., Tang, H., Micallef, I. N. M., Ansell, S. M., Link, B. K., Inwards, D. J., Porrata, L. F., Johnston, P. B., Colgan, J. P., Markovic, S. N., Nowakowski, G. S., Thompson, C. A., Allmer, C., Maurer, M. J., Gupta, M., Weiner, G., Hohl, R., Kurtin, P. J., Ding, H., Loegering, D. & 4 others, Schneider, P., Peterson, K., Habermann, T. M. & Kaufmann, S. H., Nov 3 2011, In : Blood. 118, 18, p. 4882-4889 8 p.

Research output: Contribution to journalArticle

tipifarnib
Farnesyltranstransferase
Refractory materials
Non-Hodgkin's Lymphoma
Lymphoma
73 Citations (Scopus)

O2⋅− and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate

Schoenfeld, J. D., Sibenaller, Z. A., Mapuskar, K. A., Wagner, B. A., Cramer-Morales, K. L., Furqan, M., Sandhu, S., Carlisle, T. L., Smith, M. C., Abu Hejleh, T., Berg, D. J., Zhang, J., Keech, J., Parekh, K. R., Bhatia, S., Monga, V., Bodeker, K. L., Ahmann, L., Vollstedt, S., Brown, H. & 15 others, Shanahan Kauffman, E. P., Schall, M. E., Hohl, R., Clamon, G. H., Greenlee, J. D., Howard, M. A., Shultz, M. K., Smith, B. J., Riley, D. P., Domann, F. E., Cullen, J. J., Buettner, G. R., Buatti, J. M., Spitz, D. R. & Allen, B. G., Apr 10 2017, In : Cancer Cell. 31, 4, p. 487-500.e8

Research output: Contribution to journalArticle

Glioblastoma
Non-Small Cell Lung Carcinoma
Pharmacology
Neoplasms
Iron
1 Citation (Scopus)

Personalized medicine: Through the looking glass of functional imaging

Hohl, R. J., Aug 1 2013, In : Clinical Cancer Research. 19, 15, p. 4024-4026 3 p.

Research output: Contribution to journalArticle

Precision Medicine
Glass
Pharmaceutical Preparations
Drug Therapy
Neoplasms
62 Citations (Scopus)

Pharmacodynamic effects of high dose lovastatin in subjects with advanced malignancies

Holstein, S. A., Knapp, H. R., Clamon, G. H., Murry, D. J. & Hohl, R., Jan 1 2006, In : Cancer Chemotherapy and Pharmacology. 57, 2, p. 155-164 10 p.

Research output: Contribution to journalArticle

Pharmacodynamics
Lovastatin
Bioactivity
Neoplasms
Cholesterol
22 Citations (Scopus)

Pharmacokinetic tracer kinetics analysis of changes in erythropoietin receptor population in phylebotomy-induced anemia and bone marrow ablation

Veng-Pedersen, P., Chapel, S., Al-Huniti, N. H., Schimdt, R. L., Sedars, E. M., Hohl, R. J. & Widness, J. A., May 1 2004, In : Biopharmaceutics and Drug Disposition. 25, 4, p. 149-156 8 p.

Research output: Contribution to journalArticle

Erythropoietin Receptors
Phlebotomy
Anemia
Pharmacokinetics
Bone Marrow
7 Citations (Scopus)

Phase 1 study of tabalumab, a human anti-B-cell activating factor antibody, and bortezomib in patients with relapsed/refractory multiple myeloma

Raje, N. S., Faber, E. A., Richardson, P. G., Schiller, G., Hohl, R. J., Cohen, A. D., Forero, A., Carpenter, S., Nguyen, T. S., Conti, I., Kaiser, C. J., Cronier, D. M., Wooldridge, J. E. & Anderson, K. C., Dec 1 2016, In : Clinical Cancer Research. 22, 23, p. 5688-5695 8 p.

Research output: Contribution to journalArticle

B-Cell Activating Factor
Multiple Myeloma
Antibodies
Peripheral Nervous System Diseases
Neutropenia
61 Citations (Scopus)

Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101

Miller, A. A., Murry, D. J., Owzar, K., Hollis, D. R., Lewis, L. D., Kindler, H. L., Marshall, J. L., Villalona-Calero, M. A., Edelman, M. J., Hohl, R. J., Lichtman, S. M. & Ratain, M. J., Jul 20 2007, In : Journal of Clinical Oncology. 25, 21, p. 3055-3060 6 p.

Research output: Contribution to journalArticle

Pharmacokinetics
Kidney
Liver
Neoplasms
Erlotinib Hydrochloride
153 Citations (Scopus)

Phase i and pharmacokinetic study of sorafenib in patients with hepatic or renal dysfunction: CALGB 60301

Miller, A. A., Murry, D. J., Owzar, K., Hollis, D. R., Kennedy, E. B., Abou-Alfa, G., Desai, A., Hwang, J., Villalona-Calero, M. A., Dees, E. C., Lewis, L. D., Fakih, M. G., Edelman, M. J., Millard, F., Frank, R. C., Hohl, R. J. & Ratain, M. J., Apr 10 2009, In : Journal of Clinical Oncology. 27, 11, p. 1800-1805 6 p.

Research output: Contribution to journalArticle

Pharmacokinetics
Bilirubin
Kidney
Liver
Creatinine
5 Citations (Scopus)

Phase I and pharmacokinetic study of the novel anthracycline derivative 5-imino-13-deoxydoxorubicin (GPX-150) in patients with advanced solid tumors

Holstein, S. A., Bigelow, J. C., Olson, R. D., Vestal, R. E., Walsh, G. M. & Hohl, R., Jun 22 2015, In : Investigational New Drugs. 33, 3, p. 594-602 9 p.

Research output: Contribution to journalArticle

Anthracyclines
Pharmacokinetics
Neoplasms
Maximum Tolerated Dose
Neutropenia
165 Citations (Scopus)

Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and leukemia group B 9565

Venook, A. P., Egorin, M. J., Rosner, G. L., Hollis, D., Mani, S., Hawkins, M., Byrd, J., Hohl, R., Budman, D., Meropol, N. J. & Ratain, M. J., Jan 1 2000, In : Journal of Clinical Oncology. 18, 14, p. 2780-2787 8 p.

Research output: Contribution to journalArticle

gemcitabine
Kidney Neoplasms
Leukemia
Pharmacokinetics
Liver
101 Citations (Scopus)

Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and leukemia group B 9264

Venook, A. P., Egorin, M. J., Rosner, G. L., Brown, T. D., Jahan, T. M., Batist, G., Hohl, R., Budman, D., Ratain, M. J., Kearns, C. M. & Schilsky, R. L., Jan 1 1998, In : Journal of Clinical Oncology. 16, 5, p. 1811-1819 9 p.

Research output: Contribution to journalArticle

Liver Neoplasms
Paclitaxel
Leukemia
Pharmacokinetics
Bilirubin
82 Citations (Scopus)

Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: Cancer and leukemia group B study 9473

Burns, C. P., Halabi, S., Clamon, G. H., Hars, V., Wagner, B. A., Hohl, R., Lester, E., Kirshner, J. J., Vinciguerra, V. & Paskett, E., Dec 1999, In : Clinical Cancer Research. 5, 12, p. 3942-3947 6 p.

Research output: Contribution to journalArticle

Cachexia
Fish Oils
Capsules
Leukemia
Fatty Acids
107 Citations (Scopus)

Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma

Gronchi, A., Bui, B. N., Bonvalot, S., Pilotti, S., Ferrari, S., Hohenberger, P., Hohl, R. J., Demetri, G. D., Le cesne, A., Lardelli, P., Pérez, I., Nieto, A., Tercero, J. C., Alfaro, V., Tamborini, E. & Blay, J. Y., Mar 1 2012, In : Annals of Oncology. 23, 3, p. 771-776 6 p.

Research output: Contribution to journalArticle

trabectedin
Myxoid Liposarcoma
Phase II Clinical Trials
Liposarcoma
Confidence Intervals
50 Citations (Scopus)

Phase III randomised study of dexamethasone with or without oblimersen sodium for patients with advanced multiple myeloma

Chanan-Khan, A., Niesvizky, R., Hohl, R., Zimmerman, T. M., Christiansen, N. P., Schiller, G. J., Callander, N., Lister, J., Oken, M. & Jagannath, S., Aug 17 2009, In : Leukemia and Lymphoma. 50, 4, p. 559-565 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Myeloma Proteins
Antisense Oligonucleotides
Cytotoxins
38 Citations (Scopus)

Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207

Rosenberg, J. E., Halabi, S., Sanford, B. L., Himelstein, A. L., Atkins, J. N., Hohl, R. J., Millard, F., Bajorin, D. F. & Small, E. J., May 1 2008, In : Annals of Oncology. 19, 5, p. 946-950 5 p.

Research output: Contribution to journalArticle

Transitional Cell Carcinoma
Carcinoma
Confidence Intervals
Hypernatremia
Lymphopenia
74 Citations (Scopus)

Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia: A cancer and leukemia group B study

Burns, C. P., Halabi, S., Clamon, G., Kaplan, E., Hohl, R., Atkins, J. N., Schwartz, M. A., Wagner, B. A. & Paskett, E., Jul 15 2004, In : Cancer. 101, 2, p. 370-378 9 p.

Research output: Contribution to journalArticle

Cachexia
Fish Oils
Capsules
Leukemia
Neoplasms
3 Citations (Scopus)

Phase II trial of edatrexate in patients with metastatic colorectal cancer

Clamon, G. H., Riggs, C. E., Dreicer, R. & Hohl, R., Dec 1 1995, In : Investigational New Drugs. 13, 4, p. 359-361 3 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Colonic Neoplasms
Heterografts
Nude Mice
Human Activities
333 Citations (Scopus)

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer

Thibault, A., Samid, D., Tompkins, A. C., Figg, W. D., Cooper, M. R., Hohl, R., Trepel, J., Liang, B., Patronas, N., Venzon, D. J., Reed, E. & Myers, C. E., Mar 1 1996, In : Clinical Cancer Research. 2, 3, p. 483-491 9 p.

Research output: Contribution to journalArticle

Lovastatin
Mevalonic Acid
Ubiquinone
Neoplasms
Muscular Diseases
5 Citations (Scopus)

Phosphonate analogues of cytosine arabinoside monophosphate

Chen, X., Jung, K. Y., Wiemer, D. F., Wiemer, A. J. & Hohl, R., Nov 14 2002, In : Phosphorus, Sulfur and Silicon and Related Elements. 177, 6-7, p. 1783-1786 4 p.

Research output: Contribution to journalArticle

Cytidine
Organophosphonates
K562 Cells
Cytarabine
Nucleosides
93 Citations (Scopus)

Phosphonate and bisphosphonate analogues of farnesyl pyrophosphate as potential inhibitors of farnesyl protein transferase

Holstein, S. A., Cermak, D. M., Wiemer, D. F., Lewis, K. & Hohl, R., Jan 1 1998, In : Bioorganic and Medicinal Chemistry. 6, 6, p. 687-694 8 p.

Research output: Contribution to journalArticle

Organophosphonates
Diphosphonates
Transferases
Bromides
citral
45 Citations (Scopus)

Pivaloyloxymethyl-modified isoprenoid bisphosphonates display enhanced inhibition of cellular geranylgeranylation

Wiemer, A. J., Yu, J. S., Shull, L. W., Barney, R. J., Wasko, B. M., Lamb, K. M., Hohl, R. J. & Wiemer, D. F., Apr 1 2008, In : Bioorganic and Medicinal Chemistry. 16, 7, p. 3652-3660 9 p.

Research output: Contribution to journalArticle

Prenylation
Terpenes
Diphosphonates
Farnesyltranstransferase
Display devices
12 Citations (Scopus)

Pleiotropic effects of a schweinfurthin on isoprenoid homeostasis

Holstein, S. A., Kuder, C. H., Tong, H. & Hohl, R., Oct 1 2011, In : Lipids. 46, 10, p. 907-921 15 p.

Research output: Contribution to journalArticle

Terpenes
Lovastatin
Homeostasis
Biosynthetic Pathways
Cells
1 Citation (Scopus)

Primary cutaneous polymorphic ebv-associated posttransplant lymphoproliferative disorder after a renal transplant and review of the literature

Ferguson, N. N., Thomas, C. P., Hohl, R., Syrbu, S. I., Stone, M. S. & Wanat, K. A., Oct 1 2015, In : American Journal of Dermatopathology. 37, 10, p. 790-794 5 p.

Research output: Contribution to journalArticle

Lymphoproliferative Disorders
Transplants
Kidney
Skin
Human Herpesvirus 4
13 Citations (Scopus)

Prophylactic reinfusion of T cells for T cell-depleted allogeneic bone marrow transplantation

Lee, C. K., Gingrich, R. D., DeMagalhaes-Silverman, M., Hohl, R., Joyce, J. K., Scott, S. D., Wen, B. C. & Schlueter, A., Jan 1 1999, In : Biology of Blood and Marrow Transplantation. 5, 1, p. 15-27 13 p.

Research output: Contribution to journalArticle

Homologous Transplantation
Bone Marrow Transplantation
T-Lymphocytes
Transplants
Leukemia
10 Citations (Scopus)

Prophylactic T cell infusion after T cell-depleted bone marrow transplantation in patients with refractory lymphoma

Lee, C. K., De Magalhaes-Silverman, M., Hohl, R. J., Hayashi, M., Buatti, J., Wen, B. C., Schlueter, A., Strauss, R. G. & Gingrich, R. D., Jan 1 2002, In : Bone Marrow Transplantation. 29, 7, p. 615-620 6 p.

Research output: Contribution to journalArticle

Graft vs Host Disease
Bone Marrow Transplantation
Lymphoma
T-Lymphocytes
Survival

Prophylactic T cell infusion after T cell-depleted bone marrow transplantation in patients with refractory lymphoma

Lee, C. K., de Magalhaes-Silverman, M., Hohl, R., Hayashi, M., Buatti, J., Wen, B. C., Schlueter, A., Strauss, R. G. & Gingrich, R. D., Jun 1 2002, In : Bone Marrow Transplantation. 29, 7, p. 615-620 6 p.

Research output: Contribution to journalArticle

Graft vs Host Disease
Bone Marrow Transplantation
Lymphoma
T-Lymphocytes
Survival
6 Citations (Scopus)

Putative multifunctional signature of lung metastases in dedifferentiated chondrosarcoma

Malchenko, S., Seftor, E. A., Nikolsky, Y., Hasegawa, S. L., Kuo, S., Stevens, J. W., Poyarkov, S., Nikolskaya, T., Kucaba, T., Wang, M., Abdulkawy, H., Casavant, T., Morcuende, J., Buckwalter, J., Hohl, R., Deyoung, B., Kernstine, K., Bonaldo, M. D. F., Hendrix, M. J. C., Soares, M. B. & 1 others, Soares, V. M. F. C., Mar 16 2012, In : Sarcoma. 2012, 820254.

Research output: Contribution to journalArticle

Chondrosarcoma
Neoplasm Metastasis
Lung
Gene Expression Profiling
Transcriptome
33 Citations (Scopus)

Quantitative determination of farnesyl and geranylgeranyl diphosphate levels in mammalian tissue

Tong, H., Wiemer, A. J., Neighbors, J. D. & Hohl, R. J., Jul 15 2008, In : Analytical Biochemistry. 378, 2, p. 138-143 6 p.

Research output: Contribution to journalArticle

Tissue
Terpenes
Biosynthesis
Transferases
Hydroxymethylglutaryl-CoA Reductase Inhibitors
8 Citations (Scopus)

Quantitative determination of geranyl diphosphate levels in cultured human cells

Holstein, S. A., Tong, H., Kuder, C. H. & Hohl, R., Nov 1 2009, In : Lipids. 44, 11, p. 1055-1062 8 p.

Research output: Contribution to journalArticle

Terpenes
Cultured Cells
Cells
zoledronic acid
Biosynthetic Pathways
4 Citations (Scopus)

Quantitative determination of isopentenyl diphosphate in cultured mammalian cells

Tong, H., Kuder, C. H., Wasko, B. M. & Hohl, R., Feb 1 2013, In : Analytical Biochemistry. 433, 1, p. 36-42 7 p.

Research output: Contribution to journalArticle

Cultured Cells
Cells
zoledronic acid
Lovastatin
Biosynthetic Pathways
28 Citations (Scopus)

Regulation of fatty acid synthesis by farnesyl pyrophosphate

Murthy, S., Tong, H. & Hohl, R. J., Dec 23 2005, In : Journal of Biological Chemistry. 280, 51, p. 41793-41804 12 p.

Research output: Contribution to journalArticle

Mevalonic Acid
Fatty Acids
Terpenes
Biosynthesis
Liver
23 Citations (Scopus)

Renal failure and recovery associated with second-generation Bcr-Abl kinase inhibitors in imatinib-resistant chronic myelogenous leukemia

Holstein, S. A., Stokes, J. B. & Hohl, R., Feb 1 2009, In : Leukemia Research. 33, 2, p. 344-347 4 p.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Renal Insufficiency
Phosphotransferases
Kidney
Protein-Tyrosine Kinases

Schweinfurthin natural products induce regression of murine melanoma and pair with anti-PD-1 therapy to facilitate durable tumor immunity

Kokolus, K. M., Haley, J. S., Koubek, E. J., Gowda, R., Dinavahi, S. S., Sharma, A., Claxton, D., Helm, K., Drabick, J., Robertson, G., Neighbors, J., Hohl, R. & Schell, T., Feb 1 2019, In : OncoImmunology. 8, 2, e1539614.

Research output: Contribution to journalArticle

Biological Products
Immunity
Melanoma
Immunotherapy
Neoplasms